These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8932822)

  • 21. The role of thiotepa in allogeneic bone marrow transplantation for genetic diseases.
    Rosales F; Peylan-Ramu N; Cividalli G; Varadi G; Or R; Naparstek E; Slavin S; Nagler A
    Bone Marrow Transplant; 1999 May; 23(9):861-5. PubMed ID: 10338039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recovery from CMV esophagitis after allogeneic bone marrow transplantation using non-myeloablative conditioning: the role of immunosuppression.
    Fiegl M; Gerbitz A; Gaeta A; Campe H; Jaeger G; Kolb HJ
    J Clin Virol; 2005 Nov; 34(3):219-23. PubMed ID: 16129661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal function after autologous bone marrow transplantation in children: a long-term prospective study.
    Frisk P; Bratteby LE; Carlson K; Lönnerholm G
    Bone Marrow Transplant; 2002 Jan; 29(2):129-36. PubMed ID: 11850707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic analysis of unrelated allogeneic bone marrow transplantation: results from the randomized clinical trial of T-cell depletion vs unmanipulated grafts for the prevention of graft-versus-host disease.
    de Lissovoy G; Hurd D; Carter S; Beatty P; Ewell M; Henslee-Downey J; Kernan N; Yanovich S; Weisdorf D
    Bone Marrow Transplant; 2005 Sep; 36(6):539-46. PubMed ID: 16044144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of allogeneic bone marrow transplantation on pulmonary function in 80 children in a single paediatric centre.
    Bruno B; Souillet G; Bertrand Y; Werck-Gallois MC; So Satta A; Bellon G
    Bone Marrow Transplant; 2004 Jul; 34(2):143-7. PubMed ID: 15170172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia.
    Azuma E; Kojima S; Kato K; Matsuyama T; Yamada Y; Kondo N; Sawada H; Hanada M; Shibata T; Tabata N; Watanabe M; Shimono Y; Deguchi T; Umemoto M; Higashikawa M; Kawasaki H; Komada Y; Sakurai M
    Bone Marrow Transplant; 1997 Jun; 19(11):1085-7. PubMed ID: 9193750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemolytic uremic syndrome after bone marrow transplantation: clinical characteristics and outcome in children.
    Hale GA; Bowman LC; Rochester RJ; Benaim E; Heslop HE; Krance RA; Horwitz EM; Cunningham JM; Tong X; Srivastava DK; Handgretinger R; Jones DP
    Biol Blood Marrow Transplant; 2005 Nov; 11(11):912-20. PubMed ID: 16275594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure.
    Teinturier C; Hartmann O; Valteau-Couanet D; Benhamou E; Bougneres PF
    Bone Marrow Transplant; 1998 Nov; 22(10):989-94. PubMed ID: 9849696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.
    Jillella AP; Doria R; Khan K; Zelterman D; Ahmad YH; Smith BR; Holmes W; Becker P; Roberts KB; Rappeport JM
    Bone Marrow Transplant; 1999 Jun; 23(11):1095-100. PubMed ID: 10382947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine.
    Childs R; Sanchez C; Engler H; Preuss J; Rosenfeld S; Dunbar C; van Rhee F; Plante M; Phang S; Barrett AJ
    Bone Marrow Transplant; 1998 Nov; 22(9):889-93. PubMed ID: 9827817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safe and efficacious allogeneic bone marrow transplantation for nonmalignant disorders using partial T cell depletion and no posttransplantation graft-versus-host-disease prophylaxis.
    Elhasid R; Arush MB; Zaidman I; Leiba R; Barak AB; Postovsky S; Haddad N; Katz T; Pollack S; Sami I; Gidoni O; Rubin D; Mandel H; Attias D; Reisner Y; Etzioni A; Rowe JM
    Biol Blood Marrow Transplant; 2007 Mar; 13(3):329-38. PubMed ID: 17317586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
    Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Life-threatening neurological complications after bone marrow transplantation in children.
    Uckan D; Cetin M; Yigitkanli I; Tezcan I; Tuncer M; Karasimav D; Oguz KK; Topçu M
    Bone Marrow Transplant; 2005 Jan; 35(1):71-6. PubMed ID: 15531898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
    Bartsch K; Al-Ali H; Reinhardt A; Franke C; Hudecek M; Kamprad M; Tschiedel S; Cross M; Niederwieser D; Gentilini C
    Transplantation; 2009 Jan; 87(2):217-21. PubMed ID: 19155975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
    Sao H; Kitaori K; Kasai M; Shimokawa T; Kato C; Yamanishi H; Ueda R; Morishima Y
    Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful renal transplantation following prior bone marrow transplantation in pediatric patients.
    Thomas SE; Hutchinson RJ; DebRoy M; Magee JC
    Pediatr Transplant; 2004 Oct; 8(5):507-12. PubMed ID: 15367289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bone marrow transplantation for severe aplastic anemia].
    Bullorsky EO; Bonduel M; Shanley C; Figueroa C; Stemmelin G; Del Pozo A; Ceresetto J; Delfino S; Puppo M; Muriel FS
    Medicina (B Aires); 1998; 58(2):130-4. PubMed ID: 9706244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paediatric allogeneic bone marrow transplantation for homozygous beta-thalassaemia, the Dutch experience.
    Ball LM; Lankester AC; Giordano PC; van Weel MH; Harteveld CL; Bredius RG; Smiers FJ; Egeler RM; Vossen JM
    Bone Marrow Transplant; 2003 Jun; 31(12):1081-7. PubMed ID: 12796787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allogeneic bone marrow transplantation in children - eight years experience of Paediatric BMT Unit in Poznań.
    Wachowiak J; Boruczkowski D; Malicki J; Kaczmarek-Kanold M; Chobot-Musiałkiewicz U; Radwańska U
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S63-6. PubMed ID: 9916639
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.